ScholarIQanswers from OpenAlex & ORCID
Kylie Shackleton
ResearcherPublications, citations & collaboration network
Kylie Shackleton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kylie Shackleton have?
ScholarIQindexed works
Kylie Shackleton has 36 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kylie Shackleton have?
ScholarIQcitation count
Kylie Shackleton has 608 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kylie Shackleton?
ScholarIQh-index
Kylie Shackleton has an h-index of 9 in OpenAlex.
What is the i10-index of Kylie Shackleton?
ScholarIQi10-index
Kylie Shackleton has an i10-index of 9 in OpenAlex.
What is the OpenAlex record for Kylie Shackleton?
ScholarIQopenalex
The OpenAlex for Kylie Shackleton is on the source record.
What are the most-cited papers on Kylie Shackleton?
ScholarIQmost cited works
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ní Raghallaigh, D. Gareth Evans, Jeanette Rothwell, Lovise Mæhle, Eli Marie Grindedal, Paul A. James, Lyon Mascarenhas, Joanne McKinley, Lucy Side, Tessy Thomas, Christi J. van Asperen, Hans F. A. Vasen, Lambertus A. Kiemeney, Janneke Ringelberg, Thomas D. Jensen, Palle Jørn Sloth Osther, Brian T. Helfand, Elena Genova, Rogier A. Oldenburg, Cezary Cybulski, Dominika Wokołorczyk, Kai‐Ren Ong, Camilla Huber, Jimmy Lam, Louise Taylor, Mónica Salinas, Lídia Feliubadaló, Jan C. Oosterwijk, Wendy van Zelst-Stams, Jackie Cook, Derek J. Rosario, Susan M. Domchek, Jacquelyn M. Powers, Saundra S. Buys, Karen O’Toole, Margreet G.E.M. Ausems, Rita K. Schmutzler, Kerstin Rhiem, Louise Izatt, Vishakha Tripathi, Manuel R. Teixeira, Marta Cardoso, William D. Foulkes, Armen Aprikian, Heleen van Randeraad, Rosemarie Davidson, Mark Longmuir, Mariëlle Ruijs, Apollonia T.J.M. Helderman van den Enden, Muriel A. Adank, Rachel Williams, Lesley Andrews, Declan G. Murphy, Dorothy Halliday, Lisa Walker, Annelie Liljegren, Stefan Carlsson, Ashraf Azzabi, Irene Jobson, Catherine Morton, Kylie Shackleton, Katie Snape, Helen Hanson, Marion Harris, Marc Tischkowitz, Amy Taylor, Judy Kirk, Rachel Susman, Rakefet Chen‐Shtoyerman, Allan D. Spigelman, Nicholas Pachter, Munaza Ahmed, Teresa Ramón y Cajal, Janez Žgajnar, Carole Brewer, Neus Gadea, Angela F. Brady, Theo van Os, David Gallagher, Oskar T. Johannsson, Alan Donaldson, Julian Barwell, Nicola Nicolai, Eitan Friedman, Elias Obeid, Lynn Greenhalgh, Vedang Murthy, Lucia Copáková, Sibel Saya, John McGrath, Peter Cooke
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer
Sheau Wen Lok, James R. Whittle, François Vaillant, Charis E. Teh, Louisa L. Lo, Antonia N. Policheni, Alice R.T. Bergin, Jayesh Desai, Sarah Ftouni, Luke C. Gandolfo, Danny Liew, He K. Liu, G. Bruce Mann, Kate Moodie, Anand Murugasu, Bhupinder Pal, Andrew W. Roberts, Mark Rosenthal, Kylie Shackleton, Maria João Silva, Zhen R. Siow, Gordon K. Smyth, Leanne S. Taylor, Avraham Travers, Belinda Yeo, Miriam M. Yeung, Andjelija Zivanovic Bujak, Sarah‐Jane Dawson, Daniel H.D. Gray, Jane E. Visvader, Geoffrey J. Lindeman
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
Elizabeth Bancroft, Elizabeth Page, Mark N. Brook, Sarah Thomas, Natalie Taylor, Jennifer Pope, Jana McHugh, Ann-Britt Jones, Questa Karlsson, Susan Merson, Kai Ren Ong, Jonathan Hoffman, Camilla Huber, Lovise Mæhle, Eli Marie Grindedal, Astrid Stormorken, D. Gareth Evans, Jeanette Rothwell, Fiona Lalloo, Angela F. Brady, Marion Bartlett, Katie Snape, Helen Hanson, Paul A. James, Joanne McKinley, Lyon Mascarenhas, Sapna Syngal, Chinedu Ukaegbu, Lucy Side, Tessy Thomas, Julian Barwell, Manuel R. Teixeira, Louise Izatt, Mohnish Suri, Finlay Macrae, Nicola Poplawski, Rakefet Chen‐Shtoyerman, Munaza Ahmed, Hannah Musgrave, Nicola Nicolai, Lynn Greenhalgh, Carole Brewer, Nicholas Pachter, Allan D. Spigelman, Ashraf Azzabi, Brian T. Helfand, Dorothy Halliday, Saundra S. Buys, Teresa Ramón y Cajal, Alan Donaldson, Kathleen A. Cooney, Marion Harris, John McGrath, Rosemarie Davidson, Amy Taylor, Peter Cooke, Kathryn Myhill, Matthew Hogben, Neil K. Aaronson, Audrey Ardern‐Jones, Chris H. Bangma, Elena Castro, David P. Dearnaley, Alexander Dias, Tim Dudderidge, Diana M Eccles, Kate Green, Jórunn E. Eyfjörd, Alison Falconer, Christopher S. Foster, Henrik Grönberg, Freddie C. Hamdy, Oskar T. Johannsson, Vincent Khoo, Hans Lilja, Geoffrey J. Lindeman, Jan Lubiński, Karol Axcrona, Christos Mikropoulos, Anita Mitra, Clare Moynihan, Holly Ní Raghallaigh, Gad Rennert, Rebecca Collier, Lisa K. Adams, Julian Adlard, Rosa Alfonso, Saira Ali, Angela Andrew, Luís Araújo, Nazya Azam, Darran Ball, Queenstone Barker, Alon Basevitch, Barbara Benton, Cheryl Berlin, Nicola Bermingham, Leah H. Biller, Angela Bloss, Matilda Bradford
Exploring Australian regional cancer patients’ experiences of clinical trial participation via telehealth
Jin Joo Lee, Kate Burbury, Craig Underhill, S.J. Harris, Kylie Shackleton, Jacquiline McBurnie, Narelle McPhee, Felicity Osmond, Kathleen Wilkins, Paul Baden, Meinir Krishnasamy
Tumour morphology predicts PALB2 germline mutation status
kConFab9, ZL Teo, Elena Provenzano, Gillian S. Dite, Daniel J. Park, Carmel Apicella, Sarah Sawyer, Paul A. James, Gillian Mitchell, Alison H. Trainer, Geoffrey J. Lindeman, Kylie Shackleton, Linda Cicciarelli, Saundra S. Buys, Irene L. Andrulis, Anna Marie Mulligan, Gord Glendon, Esther M. John, Mary Beth Terry, Mary B. Daly, Fabrice Odefrey, Tú Nguyen‐Dumont, Graham G. Giles, James G. Dowty, Ingrid Winship, David E. Goldgar, John L. Hopper, Melissa C. Southey